Details
Ramizes Indications
- Artrial hypertensio (as monotherapy or in combination with other antihypertensive agents such as diuretics or calcium antagonists).
- Congestive heart failure (also in combination with a diuretic).
- Congestive heart failure that occurred during the first few days after an acute myocardial infarction.
- Non-diabetic or diabetic glomerular expressed or initial nephropathy.
- Reducing the risk of myocardial infarction, stroke or cardiovascular death in patients with high cardiovascular risk (severe coronary heart disease (with / without previous myocardial infarction), stroke history, peripheral vascular disease history or diabetes mellitus with at least one additional factor cardiovascular risk (microalbuminuria, hypertension, elevated total cholesterol levels, low HDL cholesterol, smoking)).
Administration
Ramizes is taken regardless of meals. The tablets should be swallowed whole, without chewing, drinking plenty of water.
Treatment of hypertension. The initial dose is typically 2.5 mg 1 time per day. Further, in case of insufficient antihypertensive effect dose recommended to increase it by raising 2 times every 2-3 weeks. The usual maintenance dose is 2.5-5 mg / day. The maximum permissible daily dose for adults - 10 mg. An alternative to increasing the dose of 5 mg per day Ramizesa additional application may be, for example, a diuretic or a calcium antagonist.
Contradictions
- hypersensitivity to other ACE inhibitors or to any component of the drug;
- angioedema in history;
- renal artery stenosis (unilateral or bilateral);
- hypotensive or haemodynamically unstable states;
- primary aldosteronism;
- pregnancy and breastfeeding;
- child age.

